Mergers & Acquisitions Mergers & Acquisitions

Illumina tells EU judges it and Grail were ‘used as guinea pigs’ for new referral rules

Illumina told EU judges today that the European Commission had no right to seize jurisdiction over its acquisition of cancer-testing company Grail, and ran roughshod over its procedural rights.

The US gene-sequencing company was at the EU General Court to challenge the commission’s acceptance of a referral request from France, which

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News